Dose-Ranging Safety and Immunogenicity Study of Live Attenuated Varicella-Zoster Virus Vaccine (Oka/Merck) Administered to Adults 60 Years of Age or Older.
- 1 October 2005
- journal article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 98 (Supplement) , S55
- https://doi.org/10.1097/00007611-200510001-00151
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: